Engineered AAV plays lead gene therapy venture rounds: Data Byte

Venture funding is pouring into gene therapy companies, many of which are developing next-generation technologies to overcome the dosing, tissue selectivity, immunogenicity and manufacturing challenges of first-generation products. 

Dyno Therapeutics Inc. became the latest member of the club on Thursday when it raised $100 million in a series A round led by Andreessen Horowitz. ...